Skip to main content

Table 1 Baseline characteristics of involved participants

From: Gender-specific associations between atherogenic index of plasma and the presence and severity of acute coronary syndrome in very young adults: a hospital-based observational study

Characteristics

Missing data n (%)

Total (n = 1, 478)

Non-CAD (n = 419)

ACS (n = 1, 059)

P

Demographic data

 Age, years

0 (0.00)

33 (30–35)

33 (30–35)

33 (30–35)

0.270

 Male [n(%)]

0 (0.00)

1, 373 (92.90)

368 (87.83)

1005 (94.90)

< 0.001

 Height, cm

161 (10.89)

172.64 ± 6.79

172.68 ± 7.41

172.62 ± 6.51

0.875

 Weight, kg

161 (10.89)

82.95 ± 15.32

80.22 ± 17.05

84.12 ± 14.37

< 0.001

 BMI, kg/m2

161 (10.89)

27.73 ± 4.42

26.74 ± 4.84

28.15 ± 4.15

< 0.001

Vital signs

 SBP, mmHg

1 (0.10)

124.56 ± 16.05

125.12 ± 14.48

124.34 ± 16.64

0.399

 DBP, mmHg

1 (0.10)

77.96 ± 12.37

77.95 ± 10.97

77.97 ± 12.89

0.977

 HR, bpm

1 (0.10)

75.74 ± 12.28

75.38 ± 12.55

75.88 ± 12.17

0.480

Life styles

 Smoker, n(%)

0 (0.00)

984 (66.58)

232 (55.37)

752 (71.01)

< 0.001

 Drinker, n(%)

0 (0.00)

358 (26.05)

107 (25.54)

251 (23.70)

0.459

Past history

 EH, n(%)

0 (0.00)

491 (33.22)

102 (24.34)

389 (36.73)

< 0.001

 DM, n(%)

0 (0.00)

133 (9.00)

22 (5.25)

111 (10.48)

0.001

 Dyslipidaemia, n(%)

0 (0.00)

152 (10.28)

47 (11.22)

105 (9.92)

0.449

 Prior lipid-lowing treatment, n(%)

0 (0.00)

236 (15.97)

21 (5.01)

215 (20.30)

< 0.001

Laboratory parameters

 WBC, ×109/L

27 (1.83)

8.29 ± 3.07

7.13 ± 1.88

8.70 ± 3.29

< 0.001

 RBC, × 1012/L

17 (1.15)

4.99 ± 0.45

4.98 ± 0.51

5.00 ± 0.42

0.453

 HGB, g/L

17 (1.15)

152.32 ± 14.54

152.03 ± 16.42

152.43 ± 13.78

0.629

 PLT, ×109/L

17 (1.15)

239.64 ± 61.74

224.70 ± 54.48

245.56 ± 63.46

< 0.001

 TP, g/L

16 (1.08)

69.65 ± 5.60

70.51 ± 5.55

69.31 ± 5.58

< 0.001

 PALB, g/L

27 (1.83)

0.28 ± 0.06

0.29 ± 0.06

0.27 ± 0.06

< 0.001

 BUN, g/L

4 (0.27)

4.723 ± 1.59

5.07 ± 1.53

4.59 ± 1.59

< 0.001

 CR, mmol/L

4 (0.27)

76.99 ± 16.41

77.42 ± 16.98

76.82 ± 16.18

0.532

 FBG, mmol/L

4 (0.27)

5.76 ± 1.76

5.34 ± 1.21

5.93 ± 1.91

< 0.001

 GA, %

558 (37.75)

13.33 ± 3.41

12.77 ± 1.77

13.53 ± 3.79

0.003

 HbA1C, %

564 (38.16)

6.10 ± 4.38

6.18 ± 8.79

6.08 ± 1.45

0.788

Lipid profiles

0 (0.00)

    

 TC, mmol/L

 

4.58 ± 1.35

4.36 ± 1.07

4.67 ± 1.44

< 0.001

 TG, mmol/L

 

1.82 (1.26–2.78)

1.58 (1.07–2.40)

1.95 (1.33–2.89)

< 0.001

 HDL-C, mmol/L

 

0.94 ± 0.22

1.03 ± 0.25

0.91 ± 0.21

< 0.001

 LDL-C, mmol/L

 

2.89 ± 1.13

2.68 ± 0.85

2.97 ± 1.21

< 0.001

 AIP

 

0.31 ± 0.32

0.21 ± 0.33

0.35 ± 0.30

< 0.001

CAG characteristics

0 (0.00)

    

 One-vessel, n(%)

   

519 (35.12)

 

 Two-vessel, n(%)

   

244 (16.51)

 

 Three-vessel, n(%)

   

192 (12.99)

 

 GS

   

32 (14–62.75)

 
  1. CAD coronary artery disease, ACS acute coronary syndrome, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, DM diabetes mellitus, EH essential hypertension, WBC white blood cell, RBC red blood cell, HGB hemoglobin, PLT platelet, TP total protein, PALB pre-albumin, BUN blood urea nitrogen, CR creatinine, FBG fasting blood glucose, GA glycated albumin, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, AIP atherogenic index of plasma, CAG coronary angiography, GS Gensini score
  2. Bold values indicate statistical significance